SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-137411
Filing Date
2020-12-18
Accepted
2020-12-18 16:05:16
Documents
2
Period of Report
2020-12-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2038852-5_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2038852-5_3seq1.xml 3 4096
2 EXHIBIT 24 tm2038852d5_ex-24.htm EX-24 6447
  Complete submission text file 0001104659-20-137411.txt   11989
Mailing Address 250 WEST 55TH STREET NEW YORK NY 10019
Business Address 250 WEST 55TH STREET NEW YORK NY 10019 2127105220
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Issuer) CIK: 0001742927 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address 19925 STEVENS CREEK BLVD., SUITE 100 CUPPERTINO CA 95014
Business Address
Patel Purav (Reporting) CIK: 0001818246 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38634 | Film No.: 201400646